RMA
TMO icon

Roffman Miller Associates’s Thermo Fisher Scientific TMO Stock Holding History

Roffman Miller Associates’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20M Buy
39,914
+672
+2% +$323K 1.05% 33
2026
Q1 		$19.3M Sell
39,242
-506
-1% -$275K 1.11% 31
2025
Q4 		$23M Sell
39,748
-229
-0.6% -$130K 1.26% 29
2025
Q3 		$19.4M Buy
39,977
+1,024
+3% +$477K 1.09% 31
2025
Q2 		$15.8M Buy
38,953
+1,551
+4% +$648K 0.94% 41
2025
Q1 		$18.6M Buy
37,402
+898
+2% +$486K 1.17% 34
2024
Q4 		$19M Buy
36,504
+635
+2% +$349K 1.17% 34
2024
Q3 		$22.2M Buy
35,869
+647
+2% +$383K 1.35% 31
2024
Q2 		$19.5M Buy
35,222
+721
+2% +$413K 1.28% 32
2024
Q1 		$20.1M Buy
34,501
+1,008
+3% +$566K 1.34% 32
2023
Q4 		$17.8M Buy
33,493
+945
+3% +$457K 1.27% 36
2023
Q3 		$16.5M Buy
32,548
+530
+2% +$282K 1.31% 34
2023
Q2 		$16.7M Buy
32,018
+1,129
+4% +$609K 1.26% 34
2023
Q1 		$17.8M Sell
30,889
-227
-0.7% -$128K 1.42% 29
2022
Q4 		$17.1M Buy
31,116
+166
+0.5% +$88K 1.41% 30
2022
Q3 		$15.7M Buy
30,950
+498
+2% +$279K 1.43% 30
2022
Q2 		$16.5M Buy
30,452
+300
+1% +$165K 1.43% 30
2022
Q1 		$17.8M Buy
30,152
+193
+0.6% +$111K 1.32% 32
2021
Q4 		$20M Buy
29,959
+449
+2% +$280K 1.35% 32
2021
Q3 		$16.9M Buy
29,510
+1,102
+4% +$605K 1.25% 33
2021
Q2 		$14.3M Buy
28,408
+1,535
+6% +$724K 1.09% 37
2021
Q1 		$12.3M Buy
26,873
+2,519
+10% +$1.2M 1.02% 37
2020
Q4 		$11.3M Buy
24,354
+861
+4% +$404K 0.98% 37
2020
Q3 		$10.4M Buy
23,493
+693
+3% +$286K 1% 37
2020
Q2 		$8.26M Buy
22,800
+2,610
+13% +$875K 0.82% 38
2020
Q1 		$5.73M Buy
20,190
+3,153
+19% +$994K 0.72% 39
2019
Q4 		$5.54M Buy
17,037
+7,001
+70% +$2.12M 0.55% 42
2019
Q3 		$2.92M Buy
+10,036
New +$2.87M 0.31% 45

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Roffman Miller Associates's TMO Position: Q2 2026 in Review

Roffman Miller Associates increased its Thermo Fisher Scientific (TMO) stake by 1.7% in Q2 2026, buying an estimated $323K and bringing the position to 39,914 shares worth $20M. The position accounts for 1.05% of the portfolio, ranked #33.

Roffman Miller Associates first reported a position in TMO in Q3 2019 and has held it in 28 quarters since. The position peaked at $23M in Q4 2025. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Roffman Miller Associates held 39,914 shares of Thermo Fisher Scientific worth $20M as of Q2 2026.
  • Roffman Miller Associates bought 672 Thermo Fisher Scientific shares in Q2 2026, an estimated $323K.
  • Thermo Fisher Scientific made up 1.05% of Roffman Miller Associates's portfolio in Q2 2026, its #33 holding.
  • Roffman Miller Associates first reported a position in Thermo Fisher Scientific in Q3 2019 and has held it in 28 quarters since.
  • Roffman Miller Associates's Thermo Fisher Scientific position peaked at $23M in Q4 2025.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Roffman Miller Associates's 13F filing for Q2 2026, filed 13 Jul 2026.